Citations

Clear

3314 citation(s) found for "Do, Alexander".

Analysis of high altitude cognitive task performance on multiple tests
Issa, Amine, Wentz, Robert J., Herman, Nicole , Summerfield, Doug, Kasak, A., Johnson, Bruce D., Taylor, Bryan J. , Kasak, Alexander J

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.1207.9 Get It

Background It is documented that cognitive performance can diminish with altitude, but the sensitivity of specific tests have not been investigated. Our objective was to assess and compare cognitive performance from several tests and relate this to quality of sleep and acute mountain sickness (AMS). Methods During an Everest expedition, 3 cognitive tests (Stroop, Trail Making, and a proprietary motor accuracy test) were used along with a questionnaire to assess sleep and AMS. Six athlete climbers and 9 core team members were assessed pre and post‐expedition and at several time points during the expedition (up to 17,500 ft). Results To normalize for individual differences, scores were assessed as % change from baseline. There was no difference in the variation between repeated attempts in a single testing session (0.19<p<0.87), demonstrating that each test was reproducible. There was no decrement in test scores with altitude, nor was there an association with reported sleep quality. The Stroop performance was associated with AMS (p<0.05) and trending with headache (p< 0.15). The in‐house motor test trended towards an association with AMS and headache (p<0.15). However, the trail making test was not associated with AMS/headache. Conclusion With appropriate acclimatization, cognitive performance is maintained at altitude but is linked to presence of headache and AMS. Mayo Clinic and TNF.
Changes in Body Composition and Aerobic Capacity after High Altitude Exposure in Elite Climbers
Carlson, Alex R. , Kasak, A., Issa, Amine, Summerfield, Douglas T. , Miller, Andrew D., Fuglestad, Andrew, Johnson, Bruce D., Kasak, Alexander, Taylor, Bryan J. , Fuglestad, Andrew P.

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.1207.10 Get It

BACKGROUND High altitude (HA) exposure influences appetite, protein synthesis and breakdown, and aerobic capacity. Thus, HA exposure typically causes weight (wt) loss, while the impact on aerobic capacity upon return to sea level is more variable. OBJECTIVE To examine the influence of hypobaric hypoxia on body composition and exercise capacity in elite HA climbers (n=4, 2 female) acclimating at ≥5,150 m over 2 mo. relative to trekkers (n=8, 0 female) acclimating at 5,150 m over 2 wks (Mt. Everest, Nepal). Each elite climber successfully summited Mt. Everest. METHODS Body composition (DEXA, skin folds, wt) and exercise capacity (treadmill) were assessed before and within 2 wks post HA. RESULTS HA exposure increased Hct and Hb, with peak values of 52±5% and 18±2 g/dl, and 50±3% and 17±1 g/dl for the climbers and trekkers, respectively. HA decreased lean and fat tissue in both the climbers (lean −4.4±2.3%, fat −8.2±4.0%) and trekkers (lean −1.8±1.6%, fat −5.8±6.1%) (all P ≤0.06). No change was observed in skin folds for either group. Wt decreased in the climbers (−5±2%, P <0.03) and trekkers (−3±1%, P <0.01). There was no change in VO 2max pre‐to post‐HA in either group (climbers 3.26 ± 0.37 vs. 3.27 ± 0.61 L/min; trekkers 3.60 ± 0.54 vs. 3.66 ± 0.43 L/min). CONCLUSION HA results in both lean and fat tissue loss in well acclimatized climbers and trekkers with little subsequent impact on aerobic capacity. Mayo Clinic & TNF.
Influence of Inhaled Amiloride on Lung Fluid Regulation During Normobaric Hypoxia in Healthy Humans
Wheatley, Courtney M. , Kasak, A., Carlson, Alex R. , Hulsebus, Minelle L., Snyder, Eric M., Johnson, Bruce D., Baker, Sarah E. , Miller, Andrew D, Kasak, Alexander J, Taylor, Bryan J.

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.715.9 Get It

Background Fluid flux in the lungs is influenced by factors altering accumulation or removal (e.g., stimulation of epithelium sodium channels, ENaC). Purpose To determine if ENaC are necessary in the normal fluid regulation with simulated altitude exposure. Methods/Results On separate occasions, 19 healthy subjects (27 ± 5 y) received either nebulized amiloride (ENaC antagonist) or placebo (nebulized saline) during 17 h normobaric hypoxia (FIO2 = 12.5%) in a randomized, double‐blind fashion. Lung diffusing capacity for carbon monoxide (DLCO), alveolar‐capillary membrane conductance (Dm) and pulmonary capillary blood volume (Vc) were measured via a rebreathe method before and after hypoxic exposure. DLCO was not different at baseline for the amiloride vs. placebo treatments (19 ± 5 vs. 21 ± 8 mL/min/mmHg). Hypoxic exposure increased Vc but did not change Dm in both treatments (Placebo: Vc = 43 ± 22 vs. 59±23 mL p=0.011, Dm = 35 ± 10 vs. 37 ± 12 mL/min/mmHg p=0.312; Amiloride: Vc = 38 ± 17 vs. 57 ± 22 mL p<0.01, Dm = 31 ± 8 vs. 34 ± 10 mL/min/mmHg p= 0.206). Conclusion Normobaric hypoxia did not differentially affect alveolar‐capillary conductance in amiloride and placebo conditions, suggesting that ENaC do not have a role in normal lung fluid regulation during acute hypoxic exposure. HL71478
Role of kallikrein 6‐mediated PAR signaling in astrogliosis
Yoon, Hyesook, Vandell, Alexander G., Scarisbrick, Isobel A. , Radulovic, Maja

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.1096.2 Get It

A remarkable feature of the expression of kallikrein 6 (KLK6) in the CNS is its abundance in oligodendroglia and neurons, but relative lack of expression in astrocytes. We have shown in cases of CNS injury however, that KLK6 is induced in reactive astrocytes and exhibits prolonged expression in astroglial scar tissue in cases of spinal cord injury, multiple sclerosis and glioblastoma multiforme. In this study, we address the hypothesis that KLK6 plays a role in the promotion of astrogliosis and that this occurs by selective activation of protease activated receptors (PARs). Using primary murine astrocytes we show KLK6 promotes rapid transformation from an epithelioid to a stellate morphology and secretion of interleukin 6, each a hallmark of astrogliosis. The ability of KLK6 to promote stellation was shown to occur as early as 4 hours after a single pulse of KLK6, to be dose‐dependent, and to require activation of PKC and AKT signaling cascades. The stellation promoting activities of KLK6 were further shown to depend at least in part on activation of the thrombin receptor PAR1, since these effects were reduced in astrocytes derived from PAR1‐deficient mice and by a PAR1 specific inhibitor, SCH79797. These results point to novel roles for KLK6‐mediated PAR signaling in the spectrum of events that culminate in astrogliosis. This work was supported by NIH R01 NS052741.
Changes in aortic augmentation index following systemic β‐adrenergic blockade are dependent on heart rate
Allen, Alexander R., Charkoudian, Nisha , Curry, Timothy B. , Hart, Emma C. , Joyner, Michael J. , Casey, Darren P.

Mayo Clinic

The FASEB Journal | June 15, 2021 | Volume: 24 | Issue: S1 | Pages: No page available

10.1096/fasebj.24.1_supplement.780.5 Get It

We examined the effects of acute β‐adrenergic blockade on central artery hemodynamics and wave reflection characteristics in young healthy humans. High‐fidelity radial artery waveforms were recorded non‐invasively by applanation tonometry before and after intravenous propranolol (0.25 mg/kg bolus for 5 min followed by a maintenance infusion of 0.004/mg/kg/min for 20–30 min) in fourteen subjects (9 F/5M; 27 ± 2 years). Radial blood pressure (BP) was calibrated from the brachial BP (arterial catheter). Aortic augmentation index (AI a ; a measure of amplitude and timing of arterial pressure wave reflection) and roundtrip travel time of the reflected wave to and from the periphery (Δt p ; inverse of pulse wave velocity) were calculated from the generated aortic pressure waveform and are indices of central arterial stiffness. Systemic β‐blockade reduced heart rate (HR; 60 ± 2 vs. 53 ± 2 bpm, P < 0.001) and increased AI a (9.9 ± 4.3% vs. 4.3 ± 4.4%, P < 0.05), but did not alter Δt p (156 ± 4 msec vs. 152 ± 2 msec, P = 0.34). The AI a normalized to a HR of 75bpm (AI a @75) was not increased following β‐blockade (P = 0.67). Taken together, our data indicate that the increase in AI a following systemic β‐blockade is a result of a slower HR and not due to changes in β‐ mediated vascular tone. Supported by NIH K23 DK‐082424 (TBC), AHA 2170087(ECH) and CTSA RR‐024150
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers
Amin, Mahul B. , Epstein, Jonathan I. , Hansel, Donna E. , Paner, Gladell P. , True, Larry, Bayder, Dilek, Bivalacqua, Trinity J. , Brimo, Fadi , Cheng, Liang , Cheville, John C. , Dalbagni, Guido , Falzarano, Sara M. , Gordetsky, Jennifer , Gupta, Sounak , Hes, Ondřej , Kaushal, Seema , Kunju, Lakshmi P., McKenney, Jesse K. , Netto, George J. , Osunkoya, Adeboye O. , Pan, Chin , Pivovarcikova, Kristina, Raspollini, Maria Rosaria , Reis, Henning , Trpkov, Kiril , Weyerer, Veronika , Zhou, Ming , Reuter, Victor, Cheng, Liang , Cheng, Liang , Gordetsky, Jennifer B , Trpkov, Kiril , Compérat, Éva , Al-Ahmadie, Hikmat A , Guo, Charles Chuanhai , Iyer, Gopa , Magi‐Galluzzi, Cristina , Matoso, Andres , Pan, Chin Chen, Rosenberg, Jonathan E , Rouprêt, Morgan , Shah, Rajal B. , Shariat, Shahrokh F.

Mayo Clinic

Advances in Anatomic Pathology | June 15, 2021 | Volume: 28 | Issue: 4 | Pages: 196-208

10.1097/pap.0000000000000309 | PMID 34128484 Get It

The Genitourinary Pathology Society (GUPS) undertook a critical review of the recent advances in bladder cancer focusing on important topics of high interest for the practicing surgical pathologist and urologist. This review represents the second of 2 manuscripts ensuing from this effort. Herein, we address the effective reporting of bladder cancer, focusing particularly on newly published data since the last 2016 World Health Organization (WHO) classification. In addition, this review focuses on the importance of reporting bladder cancer with divergent differentiation and variant (subtypes of urothelial carcinoma) histologies and the potential impact on patient care. We provide new recommendations for reporting pT1 staging in diagnostic pathology. Furthermore, we explore molecular evolution and classification, emphasizing aspects that impact the understanding of important concepts relevant to reporting and management of patients.
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia
Amin, Mahul B. , Epstein, Jonathan I. , True, Lawrence D. , Hansel, Donna E. , Paner, Gladell P. , Baydar, Dilek Ertoy , Bivalacqua, Trinity J. , Brimo, Fadi , Cheng, Liang , Cheville, John C. , Dalbagni, Guido , Falzarano, Sara M. , Gordetsky, Jennifer , Gupta, Sounak , Hes, O., Kaushal, Seema , Kunju, Lakshmi P., Netto, George J. , Osunkoya, Adeboye O. , Pan, Chin , Pivovarcikova, Kristina, Raspollini, Maria Rosaria , Reis, Henning , Trpkov, Kiril , Weyerer, Veronika , Zhou, Ming , McKenney, Jesse K. , Reuter, Victor E. , Cheng, Liang , Cheng, Liang , Gordetsky, Jennifer B , Trpkov, Kiril , Compérat, Éva , Al-Ahmadie, Hikmat A , Guo, Charles Chuanhai , Iyer, Gopa , Magi‐Galluzzi, Cristina , Matoso, Andres , Pan, Chin Chen, Rosenberg, Jonathan E , Rouprêt, Morgan , Shah, Rajal B. , Shariat, Shahrokh F.

Mayo Clinic

Advances in Anatomic Pathology | June 15, 2021 | Volume: 28 | Issue: 4 | Pages: 179-195

10.1097/pap.0000000000000308 | PMID 34128483 Get It

The Genitourinary Pathology Society (GUPS) undertook a critical review of the recent advances in bladder neoplasia with a focus on issues relevant to the practicing surgical pathologist for the understanding and effective reporting of bladder cancer, emphasizing particularly on the newly accumulated evidence post-2016 World Health Organization (WHO) classification. The work is presented in 2 manuscripts. Here, in the first, we revisit the nomenclature and classification system used for grading flat and papillary urothelial lesions centering on clinical relevance, and on dilemmas related to application in routine reporting. As patients of noninvasive bladder cancer frequently undergo cystoscopy and biopsy in their typically prolonged clinical course and for surveillance of disease, we discuss morphologies presented in these scenarios which may not have readily applicable diagnostic terms in the WHO classification. The topic of inverted patterns in urothelial neoplasia, particularly when prominent or exclusive, and beyond inverted papilloma has not been addressed formally in the WHO classification. Herein we provide a through review and suggest guidelines for when and how to report such lesions. In promulgating these GUPS recommendations, we aim to provide clarity on the clinical application of these not so uncommon diagnostically challenging situations encountered in routine practice, while also importantly advocating consistent terminology which would inform future work.
Systematic review and network meta‐analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation
Nelson, Alfred D. , Black, Christopher J. , Houghton, Lesley A. , Lugo‐Fagundo, Nahyr , Lacy, Brian E. , Ford, Alexander C. , Lugo-Fagundo, Nahyr Sofía, Houghton, L A , Ford, Alexander C , Black, Christopher J

Mayo Clinic

Alimentary Pharmacology & Therapeutics | June 11, 2021 | Volume: 54 | Issue: 2 | Pages: 98-108

10.1111/apt.16437 | PMID 34114657 Get It

SummaryBackgroundAlthough bloating is a highly prevalent and troublesome symptom in irritable bowel syndrome with constipation (IBS‐C), treatment is empirical with no specific guidelines for its management.AimTo conduct a pairwise and network meta‐analysis, using a frequentist approach, of Food and Drug Administration‐licensed drugs for IBS‐C comparing their efficacy for abdominal bloating as a specific endpoint.MethodsWe searched the medical literature through December 2020 to identify randomised controlled trials (RCTs) in IBS‐C, with abdominal bloating reported as a dichotomous assessment. Efficacy of each drug was reported as a pooled relative risk (RR) with 95% confidence intervals (CIs) to summarise effect of each comparison tested. Treatments were ranked according to their P‐score.ResultsWe identified 13 eligible RCTs, containing 10 091 patients. Linaclotide 290 µg o.d., lubiprostone 8 µg b.d., tenapanor 50 mg b.d. and tegaserod 6 mg b.d. were all superior to placebo for abdominal bloating in patients with IBS‐C, in both pairwise and the network meta‐analyses. Linaclotide demonstrated the greatest improvement in abdominal bloating in both pairwise and network meta‐analysis (RR of failure to achieve an improvement in abdominal bloating = 0.78; 95% CI 0.74‐0.83, number needed to treat = 7, P‐score 0.97). Indirect comparison revealed no significant differences between individual drugs.ConclusionsWe found all licensed drugs for IBS‐C to be superior to placebo for abdominal bloating. Linaclotide appeared to be the most efficacious at relieving abdominal bloating. Further research is needed to assess long‐term efficacy of these agents and to better understand the precise mechanism of improving bloating.
Brachial Plexus Birth Injuries
Pulos, Nicholas , Shaughnessy, William J. , Spinner, Robert J. , Shin, Alexander Y. , Shin, Alexander Y , Pulos, Nicholas

Mayo Clinic

JBJS Reviews | June 8, 2021 | Volume: 9 | Issue: 6 | Pages: No page available

10.2106/jbjs.rvw.20.00004 | PMID 34102666 Get It

» The incidence of brachial plexus birth injury (BPBI) in the United States is declining and now occurs in <1 per 1,000 births. » The gold standard for predicting the need for early intervention remains serial examination. » Early treatment of BPBI with reconstructive surgery requires the ability to perform both interposition nerve grafting and nerve transfers. » Given the heterogeneity of lesions, the evidence is largely limited to retrospective comparative studies and case series.
Senolytics reduce coronavirus-related mortality in old mice
Camell, Christina D. , Yousefzadeh, Matthew J. , Zhu, Yi , Prata, Larissa , Huggins, Matthew A. , Pierson, Mark , Zhang, Lei , O’Kelly, Ryan, Pirtskhalava, Tamar , Xun, Pengcheng , Ejima, Keisuke , Xue, Ailing, Tripathi, Utkarsh , Espíndola‐Netto, Jair Machado , Giorgadze, Nino, Atkinson, Elizabeth J. , Inman, Christina L., Johnson, Kurt O. , Cholensky, Stephanie H., Carlson, Timothy W. , O’Sullivan, M. Gerard , Jameson, Stephen C. , Meves, Alexander , Li, Ming , Prakash, Y. S. , Hamilton, Sara E. , Niedernhofer, Laura J. , Kirkland, James L. , Prata, Larissa G P Langhi , LeBrasseur, Nathan K , Khosla, Sundeep , O'Sullivan, M Gerard , Allison, David B , Jameson, Stephen C , Meves, Alexander , Prakash, Y S , Chiarella, Sergio E , Hamilton, Sara E , Tchkonia, T , Niedernhofer, Laura J , Kirkland, James L , Robbins, Paul D , Zhang, Lei , Zhu, Yi , O'Kelly, Ryan D., LeBrasseur, Nathan K. , Khosla, Sundeep , Allison, David B. , Chiarella, Sergio E. , Tchkonia, Tamar , Robbins, Paul D.

Mayo Clinic

Science | June 8, 2021 | Volume: 373 | Issue: 6552 | Pages: No page available

10.1126/science.abe4832 | PMID 34103349 Get It

Senescent cells exacerbate COVID-19 Cellular senescence is a state elicited in response to stress signals and is associated with a damaging secretory phenotype. The number of senescent cells increases with advanced age and this in turn drives age-related diseases. Camell et al. show that senescent cells have an amplified inflammatory response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (see the Perspective by Cox and Lord). This response is communicated to nonsenescent cells, suppressing viral defense mechanisms and increasing the expression of viral entry proteins. In old mice infected with a SARS-CoV-2–related virus, treatment with senolytics to reduce the senolytic cell burden reduced mortality and increased antiviral antibodies. Science , abe4832, this issue p. eabe4832 ; see also abi4474, p. 281